c-Myc Tag Peptide: Precision Tools for Gene Regulation and Cancer Research

Introduction

The c-Myc tag Peptide (SKU: A6003) stands at the forefront of molecular tools for dissecting transcriptional regulation and oncogenic processes. This synthetic peptide, corresponding to the C-terminal amino acids 410-419 of the human c-Myc protein, is a critical research reagent for cancer biology, immunoassays, and studies of cell proliferation and apoptosis regulation. While previous articles have extensively covered the mechanistic roles and application scenarios of the c-Myc tag Peptide, this article delves deeper into its emerging scientific utility—bridging advanced cell signaling, proto-oncogene c-Myc mediated gene amplification, and the interplay between transcription factor regulation and immune modulation.

Biochemical Properties and Solubility Profile

Peptide Structure, Purity, and Storage

The c-Myc tag Peptide offered by APExBIO is a highly purified synthetic peptide, with a molecular weight of 1203.3 Da and a purity exceeding 99%. The sequence mirrors the functional epitope recognized by anti-c-Myc antibodies, making it a robust tool for immunoassay displacement. For optimal stability, the peptide should be stored desiccated at -20°C, and reconstituted solutions are best used immediately to avoid degradation.

Solubility and Handling

This peptide demonstrates exceptional solubility: at concentrations ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (with ultrasonic treatment), but is insoluble in ethanol. These properties make it compatible with a wide array of biochemical and cell-based assays, including high-throughput screening and immunoprecipitation.

Mechanism of Action: Displacement of c-Myc-Tagged Fusion Proteins

The principal application of the c-Myc tag Peptide is as a displacement agent in immunoassays. By competitively binding to anti-c-Myc antibodies, it effectively inhibits the interaction between antibodies and c-Myc-tagged fusion proteins. This anti-c-Myc antibody binding inhibition is pivotal for enhancing assay specificity and enabling the elution of target proteins without harsh chemical treatments. The mechanism leverages the high affinity of the synthetic c-Myc peptide for the antibody’s recognition site, facilitating gentle recovery of fusion proteins for downstream analysis.

c-Myc in Transcription Factor Regulation and Cancer Biology

Role of c-Myc in Cell Proliferation and Apoptosis

c-Myc is a proto-oncogene encoding a transcription factor that orchestrates vital cellular processes—cell cycle progression, apoptosis, differentiation, and stem cell self-renewal. Upon activation, c-Myc upregulates cyclins and ribosomal RNA/proteins, while suppressing cell cycle inhibitors such as p21 and apoptosis regulators like Bcl-2. This gene transcription regulation peptide is thus integral to studies exploring cell proliferation assay peptide applications and apoptosis pathway modulation.

Gene Amplification and Oncogenic Overexpression

In cancer biology, c-Myc mediated gene amplification and overexpression drive tumorigenesis through sustained cell growth signals. The use of this cancer biology peptide reagent allows researchers to model oncogene overexpression and dissect the molecular consequences of dysregulated c-Myc pathways—an area critical for developing targeted cancer therapeutics.

Advanced Applications: Beyond Standard Immunoassays

Integration into Autophagy and Immune Regulation Studies

While most literature highlights the peptide’s utility in immunoassays, new research directions are emerging. Notably, studies on transcription factors such as IRF3 underscore the importance of regulated protein stability in immune signaling (see Wu et al., 2021). In this seminal work, IRF3’s stability—controlled via selective autophagy—balances interferon production and immune suppression. By analogy, the c-Myc tag Peptide enables precise investigation into the regulation, localization, and degradation of transcription factors, offering a platform to model how ubiquitin-mediated turnover intersects with gene expression and antiviral defenses.

Stem Cell Self-Renewal and Differentiation

c-Myc is a hallmark marker of pluripotency and a critical regulator of stem cell fate. Employing the c-Myc-tagged fusion protein displacement peptide in studies of stem cell self-renewal provides mechanistic insight into how transcription factors coordinate proliferation, differentiation, and lineage commitment.

Comparative Analysis with Alternative Methods

Traditional methods for eluting fusion proteins or modulating antibody interactions often rely on harsh denaturants or chaotropic agents, which can compromise protein activity. The synthetic c-Myc peptide for immunoassays, however, offers a gentle, specific, and reversible approach. Compared to peptides targeting other epitope tags (such as FLAG or His6), the myc tag sequence provides unique advantages in terms of antibody availability, low immunogenicity, and compatibility with multiplexed detection systems.

Earlier articles, such as the scenario-based practical guide (his6-tag.com), focus on workflow optimization and troubleshooting in immunoassays. While these are invaluable for experimental planning, the present article extends the discussion to include the peptide’s role in modeling transcriptional regulation, proto-oncogene dynamics, and systems-level cellular responses.

Novel Insights: c-Myc Peptide in Systems Biology and Immune Surveillance

Exploring the Crosstalk Between Transcription Factors and Innate Immunity

Emerging evidence highlights the interplay between oncogenic transcription factors and immune surveillance mechanisms. The study by Wu et al. (2021) reveals how selective autophagy modulates IRF3 stability, influencing both interferon signaling and apoptosis—a duality mirrored in c-Myc-driven tumors. Utilizing the anti-c-Myc antibody inhibitor peptide, researchers can track c-Myc turnover, post-translational modification states, and their impact on cell fate decisions during immune activation or suppression.

This focus on systems-level analysis differentiates our article from prior pieces such as the mechanistic exploration on America Peptides (americapeptides.com), which emphasizes immunoassay optimization and cancer pathway dissection. Our approach uniquely integrates molecular biology, immunology, and cell signaling, offering a holistic view of c-Myc’s research potential.

Technical Considerations for Experimental Design

• Myc tag sequence: EQKLISEEDL (human c-Myc 410-419)—select for high-affinity antibody interactions.
• Peptide solubility: Use DMSO for maximum concentration; avoid ethanol to prevent precipitation.
• Peptide molecular weight: 1203.3 Da—enables precise quantification and mass spectrometric analysis.
• Peptide purity >99%: Ensures minimal background in sensitive assays.
• Peptide storage at -20°C: Maintain lyophilized stability; avoid repeated freeze-thaw cycles.

These parameters are critical for reproducibility, especially in quantitative immunoassays and protein interaction studies.

Interlinking with the Content Landscape

Several recent articles have advanced the conversation around c-Myc peptide technology. For example, ALC-0315.com discusses the integration of c-Myc tag Peptide into studies of autophagy and innate immunity, mirroring aspects of IRF3 regulation. Our present article builds upon this by specifically analyzing how the c-Myc peptide can be leveraged for systems biology investigations into proto-oncogene c-Myc and its crosstalk with immune pathways—areas not fully explored in the aforementioned piece.

Meanwhile, the article at flag-peptide.com provides a comprehensive guide to experimental design and translational applications. In contrast, our focus is on the peptide’s role as a molecular probe for dissecting gene regulation networks and its potential in modeling dynamic cell fate outcomes in health and disease.

Conclusion and Future Outlook

The c-Myc tag Peptide is more than a displacement tool for immunoassays—it is a gateway to advanced research in transcription factor c-Myc regulation, oncogene amplification, cell cycle control, and immune modulation. With its high purity, solubility, and compatibility with existing workflows, this anti-c-Myc antibody binding inhibition peptide empowers researchers to explore the molecular underpinnings of cell proliferation, apoptosis, and stem cell self-renewal. As systems biology and multi-omics technologies evolve, the utility of c-Myc-driven tools will only expand, enabling new discoveries in cancer biology and beyond.

For scientists aiming to push the boundaries of gene expression, protein interaction studies, and cancer pathway elucidation, the c-Myc tag Peptide from APExBIO offers unmatched precision and versatility.